The MDeyes powder option mixes easily with water to avoid capsules, includes FloraGLO Lutein and OPTISHARP Zeaxanthin. No added gluten, dairy, sodium potassium salts, wheat, lactose, colours, flavours, preservatives. Has a great-tasting natural orange flavour with no artificial colours, flavours or added sugar. Includes a 4g scoop for dosage compliance and has $29.95 (RRP) per tub (40 serves)
In wet cases of ARM (leakage of microvessels), anti-vascular endothelial growth factor (anti-VEGF) injection may help. Whereas there are potential benefits of antioxidant supplements in cases of dry ARM
The exact mechanism by which this process occurs is not fully known. Age, genetics, and exposure to both endogenous and environmental oxidative stress are factors.
The original AREDS formula (2001) involved a randomised, multicentre, double-masked and placebo-controlled clinical trial of 4,757 patients. OVER SUBSEQUENT YEARS, the AREDS study’s follow-up results showed much data in reducing vision loss using AREDS had proven antioxidants.
A further AREDS2 Research Group followed 4,203 patients. It showed, particularly in patients with a history of smoking and/or a low dietary intake of lutein and zeaxanthin, that an improved formula could be used. Also, beta-carotene was removed as well as using a lower dose of zinc.
Of the hundreds of carotenoids in normal diets, only lutein and zeaxanthin are naturally concentrated within the macula. They provide antioxidative and anti-inflammatory properties and short-wavelength blue light protection.
Accordingly, an increased dietary intake of lutein and zeaxanthin may be protective against the development of late AMD but not early AMD. Omega-3 long-chain polyunsaturated fatty acids and other particular acids have also been studied trying to improve the formula.